ROCKY BOTTOM ROUGHNESS ALONG THE CALIFORNIA COAST

The roughness of ninety-nine rocky bottoms is measured for nearshore bathymetric surveys (depths >5m to several km offshore) resolved at 1 or 2m extending the length of California. Visual inspection shows a wide variety of rock formations comprising the bottoms. Many flat areas are found in depressions amongst the rocks that presumably are filled with sediments. Roughness is measured as the standard deviation of the residual elevation, σ_z, about a mean planform that is averaged over 750m in the alongshore and cross-shore. The σ_z vary from 0.35m to 8.6m with a mean of 2.1m. The measured rocky bottoms are significantly rougher than previously measured coral reef bottoms. Roughness scale is determined from ensemble-averaged wavenumber (k) spectra of elevation, (G_zz ) ̂(k), and of bottom slopes, ( G_ββ ) ̂(k) in both the cross-shore (x) and alongshore (y). All (G_zz ) ̂(k) are red with maximum variance at low wavenumber with slopes increasing from -1 to -3, have similar shapes, and appear near isotropic in x and y. Assuming a power law relationship in k, the slopes of (G_zz ) ̂(k), denoted as (α_z ) ̂(k), are shown to be related to the slopes of (G_ββ ) ̂(k), denoted as(〖 α〗_β ) ̂(k), by log (α_β ) ̂(k)=log (α_z ) ̂(k) +2 in x and y. Both (α_z ) ̂(k) and (α_β ) ̂(k) are isotropic in x and y evidenced by their 95% confidence intervals overlapping across the intermediate wavenumber scales <1/666m.ONR, Arlington, VA 22203Lieutenant Commander, United States NavyApproved for public release. Distribution is unlimited

Acyl Sugars Protect a Wild Tobacco from Both Native Fungal Pathogens and a Specialist Herbivore

O-acyl sugars (O-AS) are abundant trichome-specific metabolites that function as indirect defenses against herbivores of the wild tobacco Nicotiana attenuata; whether they also function as generalized direct defenses against herbivores and pathogens remains unknown. We characterized natural variation in O-AS among 26 accessions and examined their influence on two native fungal pathogens, Fusarium brachygibbosum U4 and Alternaria sp. U10, and the specialist herbivore, Manduca sexta. At least 15 different O-AS structures belonging to three classes were found in N. attenuata leaves. A three-fold quantitative variation in total leaf O-AS was found among the natural accessions. Experiments with natural accessions and crosses between high- and low-O-AS accessions revealed that total O-AS levels were associated with resistance against herbivores and pathogens. Removing O-AS from the leaf surface increased M. sexta growth rate and plant fungal susceptibility. O-AS supplementation in artificial diets and germination medium reduced M. sexta growth and fungal spore germination, respectively. Finally, silencing the expression of a putative branched-chain alpha-ketoacid dehydrogenase E1 beta subunit encoding gene (NaBCKDE1B) in the trichomes reduced total leaf O-AS by 20-30% and increased susceptibility to Fusarium pathogens. We conclude that O-AS function as direct defenses to protect plants from attack from both native pathogenic fungi and a specialist herbivore, and infer that their diversification is likely shaped by the functional interactions among these biotic stresses

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Background: Statins are the cornerstone treatment for patients with heterozygous familial hypercholesterolaemia but research suggests it could increase the risk of type 2 diabetes in the general population. A low prevalence of type 2 diabetes was reported in some familial hypercholesterolaemia cohorts, raising the question of whether these patients are protected against type 2 diabetes. Obesity is a well known risk factor for the development of type 2 diabetes. We aimed to investigate the associations of known key determinants of type 2 diabetes with its prevalence in people with heterozygous familial hypercholesterolaemia. Methods: This worldwide cross-sectional study used individual-level data from the EAS FHSC registry and included adults older than 18 years with a clinical or genetic diagnosis of heterozygous familial hypercholesterolaemia who had data available on age, BMI, and diabetes status. Those with known or suspected homozygous familial hypercholesterolaemia and type 1 diabetes were excluded. The main outcome was prevalence of type 2 diabetes overall and by WHO region, and in relation to obesity (BMI ≥30·0 kg/m2) and lipid-lowering medication as predictors. The study population was divided into 12 risk categories based on age (tertiles), obesity, and receiving statins, and the risk of type 2 diabetes was investigated using logistic regression. Findings: Among 46 683 adults with individual-level data in the FHSC registry, 24 784 with heterozygous familial hypercholesterolaemia were included in the analysis from 44 countries. 19 818 (80%) had a genetically confirmed diagnosis of heterozygous familial hypercholesterolaemia. Type 2 diabetes prevalence in the total population was 5·7% (1415 of 24 784), with 4·1% (817 of 19 818) in the genetically diagnosed cohort. Higher prevalence of type 2 diabetes was observed in the Eastern Mediterranean (58 [29·9%] of 194), South-East Asia and Western Pacific (214 [12·0%] of 1785), and the Americas (166 [8·5%] of 1955) than in Europe (excluding the Netherlands; 527 [8·0%] of 6579). Advancing age, a higher BMI category (obesity and overweight), and use of lipid-lowering medication were associated with a higher risk of type 2 diabetes, independent of sex and LDL cholesterol. Among the 12 risk categories, the probability of developing type 2 diabetes was higher in people in the highest risk category (aged 55-98 years, with obesity, and receiving statins; OR 74·42 [95% CI 47·04-117·73]) than in those in the lowest risk category (aged 18-38 years, without obesity, and not receiving statins). Those who did not have obesity, even if they were in the upper age tertile and receiving statins, had lower risk of type 2 diabetes (OR 24·42 [15·57-38·31]). The corresponding results in the genetically diagnosed cohort were OR 65·04 (40·67-104·02) for those with obesity in the highest risk category and OR 20·07 (12·73-31·65) for those without obesity. Interpretation: Adults with heterozygous familial hypercholesterolaemia in most WHO regions have a higher type 2 diabetes prevalence than in Europe. Obesity markedly increases the risk of diabetes associated with age and use of statins in these patients. Our results suggest that heterozygous familial hypercholesterolaemia does not protect against type 2 diabetes, hence managing obesity is essential to reduce type 2 diabetes in this patient population. Funding: Pfizer, Amgen, MSD, Sanofi-Aventis, Daiichi-Sankyo, and Regeneron